Ergotamine tartrate

Medihaler Ergotamine (ergotamine tartrate) is a small molecule pharmaceutical. Ergotamine tartrate was first approved as Medihaler Ergotamine on 1982-01-01. It is used to treat cluster headache, migraine disorders, and postpartum hemorrhage in the USA. It is known to target 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 1D, 5-hydroxytryptamine receptor 5A, 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 7, 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2C, and 5-hydroxytryptamine receptor 2A.